CAR T cells: engineered immune cells to treat brain cancers and beyond

Malignant brain tumors rank among the most challenging type of malignancies to manage. The current treatment protocol commonly entails surgery followed by radiotherapy and/or chemotherapy, however, the median patient survival rate is poor. Recent developments in immunotherapy for a variety of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zoufang, Dewanjee, Saikat, Chakraborty, Pratik, Jha, Niraj Kumar, Dey, Abhijit, Gangopadhyay, Moumita, Chen, Xuan-Yu, Wang, Jian, Jha, Saurabh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890802/
https://www.ncbi.nlm.nih.gov/pubmed/36721153
http://dx.doi.org/10.1186/s12943-022-01712-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890802/
https://www.ncbi.nlm.nih.gov/pubmed/36721153
http://dx.doi.org/10.1186/s12943-022-01712-8

Ejemplares similares